Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Earth Create Co. Ltd. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This prosecution is being conducted by 1 distinct examiner within 1 distinct art unit, which suggests that the company's current intellectual property is focused on a specific technical area. The involvement of only 1 distinct art unit implies that the pending application does not cross into other specialized fields of biotechnology at this time.
The busiest examiner for the portfolio is MITCHELL, EDWIN COLEMAN, who is responsible for 1 pending office action. Because the company's current workload is limited to 1 distinct examiner, the prosecution strategy must be responsive to the specific citations and arguments raised by this individual. With only 1 pending office action, the company's immediate patent office outcomes are centralized under this single examiner's review. This arrangement means that the applicant's current progress is dependent on the examination pace and style of the 1 distinct examiner identified.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MITCHELL, EDWIN COLEMAN | 1 | 32.1% | +65.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18001547 | GASTROPOD REPELLENT FILM AND PLANT CULTIVATION METHOD | MITCHELL, EDWIN COLEMAN | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18001547 | GASTROPOD REPELLENT FILM AND PLANT CULTIVATION METHOD | MITCHELL, EDWIN COLEMAN | 1619 | §103 | Non-Final OA | — | Pending | Dec 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEarth Create Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Edwin Coleman Mitchell has the most, with 1 of Earth Create Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
